Unlock instant, AI-driven research and patent intelligence for your innovation.

Solid dispersion product containing N-aryl urea-based compound

A technology for solid dispersions and products, which can be used in medical preparations containing active ingredients, organic active ingredients, chemical/physical processes, etc., and can solve problems such as low bioavailability

Inactive Publication Date: 2010-09-08
ABBOTT GMBH & CO KG
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in most cases, the oral solid dosage form of the drug has lower bioavailability than the oral solution of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solid dispersion product containing N-aryl urea-based compound
  • Solid dispersion product containing N-aryl urea-based compound
  • Solid dispersion product containing N-aryl urea-based compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0259] Example 1N-[(4R)-6-fluoro-2,2-dimethyl-3,4-dihydro-2H-benzopyran-4- Base] N'-(1-methyl-1H-indazol-4-yl)urea

Embodiment 1A

[0260] Example 1A: 6-fluoro-2,2-dimethylchroman-4-one

[0261] In a 500 mL round bottom flask was added 1-(5-fluoro-2-hydroxyphenyl)ethanone (20.0 g, 130 mmol, Aldrich Chemical), propan-2-one (19.0 mL, 260 mmol) in methanol (150 mL) and pyrrolidine (21.5 mL, 260 mmol) to give an orange solution. The reaction mixture was stirred at ambient temperature for 48 h. The reaction mixture was poured into EtOAc (200 mL), washed with 1N HCl (50 mL), saturated NaHCO 3 (50 mL) and brine (50 mL). The organic fraction was dried (Na 2 SO 4 ), filtered and concentrated to give an orange residue which was purified by silica gel chromatography (gradient elution, 0-20% EtOAc / hexanes) to give the title compound as a white solid (14.2 g, 73.1 mmol, 56%). MS (DCI / NH 3 )m / z208(M+NH 4 ) +

Embodiment 1B

[0262] Example 1B: (S)-6-fluoro-2,2-dimethylchroman-4-ol

[0263] Methyl tert-butyl ether (34 mL), (R)-diphenyl(pyrrolidin-2-yl)methanol (1.10 g, 4.35 mmol) and borane-N,N-diethylaniline complex ( A solution of 18.5 mL, 104 mmol) was heated to 45°C, then EXAMPLE 1A (16.9 g, 87.0 mmol) in methyl tert-butyl ether (136 mL) was added via addition funnel over 75 min. After the addition was complete, LCMS indicated complete reaction. After stirring at 45 °C for an additional 15 min, the reaction mixture was cooled to 10 °C and treated with MeOH (85 mL) for 10 min while maintaining the temperature ≤ 15 °C (H 2release). After stirring at ambient temperature for 30 min, 2N HCl (85 mL) was added and the reaction mixture was stirred for 10 min. Methyl tert-butyl ether (170 mL) was added and the reaction mixture was partitioned. The organic portion was washed with 2N HCl (85 mL) and brine (35 mL). The aqueous extract was back extracted with methyl tert-butyl ether (85 mL). The com...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
shear viscosityaaaaaaaaaa
shear viscosityaaaaaaaaaa
Login to View More

Abstract

A solid dispersion product comprising at least one N-aryl urea-based pharmaceutically active agent or an agent of related structural type is obtained by a) preparing a liquid mixture containing the at least one active agent, at least one pharmaceutically acceptable matrix-forming agent, at least one pharmaceutically acceptable surfactant and at least one solvent, and b) removing the solvent(s) from the liquid mixture to obtain the solid dispersion product.

Description

technical field [0001] Many potent drugs belong to the class of N-aryl urea compounds or compounds of related structural types. Unfortunately, most crystalline forms of N-arylurea-based active agents or compounds of related structural types are characterized by poor solubility in aqueous liquids. Background technique [0002] Low water solubility drugs, such as those classified as "virtually insoluble" or "insoluble" according to United States Pharmacopeia (USP) 24 (2000), p.10, i.e., having less than about 1 Drugs with a solubility of less than one part of drug (less than about 100 μg / ml) are very difficult to formulate for oral delivery. Among other problems, the bioavailability of these drugs tends to be extremely low when administered by the oral route. [0003] A specific illustrative small molecule drug of low water solubility is the compound 1-((R)-5-tert-butyl-indan-1-yl)-3-(1H-indazol-4-yl)-urea ( ABT-102), a first-in-class TRPV1 antagonist designed for the treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61K31/337B01F23/00
CPCA61K9/1652A61K9/1635A61K31/337A61K9/1617
Inventor R·施勒德T·黑特曼
Owner ABBOTT GMBH & CO KG